Target intelligence / Profile preview

Transmembrane protein 186 (TMEM186)

Target
TMEM186
Molecular classification
Transmembrane protein, Other (based on current knowledge, not a receptor, enzyme, ion channel, etc.), Mitochondrial membrane protein (part of MCIA complex for mitochondrial complex I assembly)
01

Overview

Transmembrane protein 186 (TMEM186) is a mitochondrial transmembrane protein encoded by the TMEM186 gene, located on human chromosome 16[2][7][8]. TMEM186 is a component of the MCIA complex (mitochondrial complex I assembly), where it is required for the efficient assembly of mitochondrial complex I, crucial for cellular energy production through respiratory electron transport[2][3][4][9]. Variants of TMEM186 have been associated with rare congenital disorders of glycosylation and some aspects of mitochondrial disease, but its precise biological mechanisms remain to be fully characterized[2][6][9]. As of current knowledge, TMEM186 is not a druggable therapeutic target, has no validated biomarker role, and no direct pharmacological interactions are established. Its primary annotation in disease comes from genetic and pathway studies rather than clinical application[2][4][7][9].

Other names
TMEM186C16orf51DKFZP564K2062TM186_HUMAN (UniProt protein name)
02

Mechanism of action

None identified

03

Biological functions

Mitochondrial complex I assemblyOther (potentially involved in cellular energy metabolism via respiratory electron transport)
04

Disease associations

Congenital disorder of glycosylation, type InMitochondrial disease (defective complex I assembly impacts cellular energy)Other (Indirectly: genetic studies and associations suggest relevance to some disease phenotypes, but not a validated therapeutic or biomarker target)
05

Safety considerations

None known
06

Interacting drugs

None identified
07

Biomarkers

None established for patient selection or efficacy monitoring

Beyond the preview

Go deeper on Transmembrane protein 186 (TMEM186).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 186 (TMEM186).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call